Literature DB >> 9830063

Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity.

A Arcaro1, S Volinia, M J Zvelebil, R Stein, S J Watton, M J Layton, I Gout, K Ahmadi, J Downward, M D Waterfield.   

Abstract

The cDNA for a human Class II phosphoinositide 3-kinase (PI 3-kinase C2beta) with a C2 domain was cloned from a U937 monocyte cDNA library and the enzyme expressed in mammalian and insect cells. Like other Class II PI 3-kinases in vitro, PI 3-kinase C2beta utilizes phosphatidylinositol (PI) and PI 4-monophosphate but not PI 4, 5-biphosphate as substrates in the presence of Mg2+. Remarkably, and unlike other PI 3-kinases, the enzyme can use either Mg-ATP or Ca-ATP to generate PI 3-monophosphate. PI 3-kinase C2beta, like the Class I PI 3-kinases, but unlike PI 3-kinase C2alpha, is sensitive to low nanomolar levels of the inhibitor wortmannin. The enzyme is not regulated by the small GTP-binding protein Ras. The C2 domain of the enzyme bound anionic phospholipids such as PI and phosphatidylserine in vitro, but did not co-operatively bind Ca2+ and phospholipids. Deletion of the C2 domain increased the lipid kinase activity suggesting that it functions as a negative regulator of the catalytic domain. Although presently it is not known whether PI 3-kinase C2beta is regulated by Ca2+ in vivo, our results suggest a novel role for Ca2+ ions in phosphate transfer reactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9830063     DOI: 10.1074/jbc.273.49.33082

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Hepatocyte growth factor activates phosphoinositide 3-kinase C2 beta in renal brush-border plasma membranes.

Authors:  Vladiana Crljen; Stefano Volinia; Hrvoje Banfic
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

2.  The α-isoform of class II phosphoinositide 3-kinase is necessary for the activation of ERK but not Akt/PKB.

Authors:  Z G Cui; N Y Hong; H K Kang; D H Lee; Y K Lee; D B Park
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

3.  Class III phosphoinositide 3-kinase--Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes.

Authors:  Amina Tassa; Marie Paule Roux; Didier Attaix; Daniel M Bechet
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

Review 4.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

5.  Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.

Authors:  Yu Wang; Kazuaki Yoshioka; Mohammed Ali Azam; Noriko Takuwa; Sotaro Sakurada; Yuji Kayaba; Naotoshi Sugimoto; Isao Inoki; Takaharu Kimura; Tomoyuki Kuwaki; Yoh Takuwa
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

6.  Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function.

Authors:  David P Harris; Peter Vogel; Marie Wims; Karen Moberg; Juliane Humphries; Kanchan G Jhaver; Christopher M DaCosta; Melanie K Shadoan; Nianhua Xu; Gwenn M Hansen; Sanjeevi Balakrishnan; Jan Domin; David R Powell; Tamas Oravecz
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

7.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

8.  Phosphorylation of p47phox directs phox homology domain from SH3 domain toward phosphoinositides, leading to phagocyte NADPH oxidase activation.

Authors:  Tetsuro Ago; Futoshi Kuribayashi; Hidekazu Hiroaki; Ryu Takeya; Takashi Ito; Daisuke Kohda; Hideki Sumimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-02       Impact factor: 11.205

9.  Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.

Authors:  A Arcaro; M J Zvelebil; C Wallasch; A Ullrich; M D Waterfield; J Domin
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

10.  Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.

Authors:  Mary A Grummer; Jeremy A Sullivan; Ronald R Magness; Ian M Bird
Journal:  Biochem J       Date:  2009-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.